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Abstract.  Entamoeba histolytica, a protozoan parasite, is the etiologic agent of amoebiasis in
humans. It exists in two forms—the trophozoite which is the active, dividing form, and the cyst 
which is dormant and can survive for prolonged periods outside the host. In most infected 
individuals the trophozoites exist as commensals. In a small percentage of infections, the 
trophozoites become invasive and penetrate the intestinal mucosa, causing ulcers. The 
trophozoites may reach other parts of the body—mainly liver, where they cause tissue necrosis, 
leading to life-threatening abscesses. It is thought that pathogenesis of infection by Entamoeba 
histolytica is governed at several levels, chief among them are (i) adherence of trophozoite to the 
target cell, (ii) lysis of target cell, and (iii) phagocytosis of target cell. Several molecules which 
may be involved in these processes have been identified. A lectin inhibitable by galactose and 
N-acetyl-D-galactosamine is present on the trophozoite surface. This is implicated in adherence 
of trophozoite to the target cell. Various amoebic pore-forming proteins are known, of which 
5kDa protein (amoebapore) has been extensively studied. These can insert into the lipid bilayers 
of target cells, forming ion-channels. The phagocytic potential of trophozoites is directly linked 
to virulence as measured in animal models. Factors like association of bacteria with trophozoites 
also influence virulence. Thus, pathogenesis is determined by multiple factors and a unifying 
picture taking into account the relative contributions of each factor is sought. Recent technical 
advances, which includes the development of a transfection system to introduce genes into 
trophozoites, should help to understand the mechanism of pathogenesis in amoebiasis. 
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1.  Introduction 
 
The protozoan parasite, Entamoeba histolytica, is the causative agent of amoebiasis in 
humans. According to the best estimates (Walsh 1986) approximately 48 million 
individuals suffer from amoebiasis throughout the world. In 1984, at least 40,000 deaths 
were attributed to amoebiasis. Amoebiasis is a major problem in developing countries 
such as India. This is primarily because of inadequate sanitation and contaminated 
food and drinking water. 
Pathogenesis of amoebiasis is believed to be a multistep, multifactorial process. 
Though a large number of studies have attempted to unravel the factors/molecules 
responsible for the pathogenesis of amoebiasis, the processes involved in pathogenesis 
are by no means well understood. The aspects of pathogenesis which have been 
investigated experimentally can be broadly categorized into mechanisms involving 
(i) interactions with the intestinal flora, (ii) lysis of target cell by direct adherence, 
(iii) lysis of target cell by release of toxins and (iv) phagocytosis of target cells. Each of 
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these will be discussed after a brief description of the life cycle of E. histolytica and 
pathology of amoebiasis. 
 
 
2.   Life cycle of E. histolytica 
 
The organism exists in two forms—the trophozoite or the dividing form and the 
cyst which is the dormant form. Human infection usually begins with the ingestion 
of the cyst which is present in food and/or water contaminated with human fecal 
material. Cysts survive the acidic pH of the stomach and pass into the intestine. In 
the ileo-cecal region, cysts undergo excystment and each cyst gives rise to eight 
trophozoites. These migrate to and multiply in the colon. In most cases, trophozoites 
in the intestine live as commensals. Occasionally, however, trophozoites attack 
and invade the intestinal mucosa causing dysentery and/or progress through the 
blood vessels to extra-intestinal locations like liver, brain and lungs, where they 
may form life-threatening abscesses. In the intestine, many of the trophozoites encyst 
and produce quadrinucleated cysts. Both trophozoites and cysts are excreted along 
with the feces. Cysts can survive for prolonged periods outside the host while the 
trophozoites survive only for a few hours. Trophozoites play no role in transmission 
of the disease but are responsible for producing tissue pathology. The reservoir 
of human infection is the "carrier" or asymptomatic human host who continuously 
passes cysts. 
 
 
3.  Pathology 
 
Amoebic infection of the human intestine ranges in spectrum from luminal coloniz- 
ation to mucosal invasion (Joyce and Ravdin 1988). Initially trophozoites are found in 
the intestinal lumen and within mucosa (Brandt and Perez-Tamayo 1970). Following 
attachment to interglandular epithelium, the trophozoites have been found associated 
with the microulcerations of the mucosa. Symptoms at this stage include non-specific 
colitis with edematous mucosa and hemorrhage (Pittman and Henniger 1974). Follow- 
ing attachment of amoeba, there is considerable disintegration of epithelial cell layer 
followed by invasion of submucosa. The human inflammatory response to amoebic 
invasion is poor. This may be because Ε. histolytica can lyse inflammatory cells 
(Guerrant et al 1981; Salata et al 1985). With time the ulcer extends into lamina propria 
and further into muscularis mucosa, where progress usually stops prior to perforation. 
A plug of necrotic debris accumulates at the center of the ulcer. Trophozoites are found 
in the leading edge at the base of the ulcer (Brandt and Perez-Tamayo 1970; Prathap 
and Gilman 1970). Ulcers are typically "flask-shaped" (Brandt and Perez-Tamayo 
1970). Inflammatory response may be seen at the edges of the ulcers and involves 
mononuclear and giant cells with few neutrophils (Brandt and Perez-Tamayo 1970; 
Pittman et al 1973). Ulceration of mucosa is the hallmark of invasive disease. Ulcers 
develop more frequently in caecum and ascending colon. In about 20% of acute colitis 
cases, perforations occur which results in peritonitis (Brandt and Perez-Tamayo 1970). 
Chronic ulceration results in the formation of a proliferative tuft of remaining mucosa 
that appears as a mass (termed amoeboma) in the lumen (Brandt and Perez-Tamayo 
1970; Prathap and Gilman 1970). Occasionally, trophozoites reach the liver by portal 
venules or intestinal perforation and produce abscesses. Liver abscesses, which may be 
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up to 10 cm in diameter, occur more frequently in the right lobe. Dead cells are seen in 
the center of the abscess whereas the trophozoites are found on the periphery. Bacteria 
are conspicuous by their absence in the abscesses. Ninety five per cent deaths in 
amoebiasis are due to liver abscess (Brandt and Perez-Tamayo 1970). 
 
 
4.  Pathogenesis 
 
The major limitation one faces in studying pathogenesis is the lack of a satisfactory 
animal model which can duplicate the spectrum of human disease. Nonetheless several 
species have been used as animal models to study various aspects of pathogenesis 
(Meerovitch and Chadee 1988). For example, hamsters and gerbils are most commonly 
used as models for liver disease. Trophozoites produce lesions when injected directly 
into the liver of these animals. In vitro models are also available for studying various 
steps involved in pathogenesis (Petri and Ravdin 1988). For example, adherence can be 
scored by using Chinese hamster ovary (CHO) cells, erythrocytes or bacteria. Lysis can 
be scored as per cent cell culture monolayers disrupted. The number of erythrocytes 
ingested per trophozoite can be used as a measure of phagocytosis. One or more 
experimental approaches have been taken to study the killing of target cells by 
E. histolytica trophozoites. The processes/interactions which are thought to influence, 
or are implicated in, pathogenesis are described below. 
 
 
4.1  Colonization and interaction with the intestinal flora 
 
In the gut the trophozoites are constantly interacting with the intestinal flora. Studies 
have shown that trophozoites undergo changes on interacting with bacteria. Axenic 
E. histolytica which have lost virulence can regain it if associated with bacteria like 
Escherichia coli, Salmonella typhosa or S. paratyphi. Bacterial strains which do not 
attach to, and get ingested by, trophozoites do not affect virulence (Bracha et al 1982). 
Virulence of trophozoites of strain 200:NIH varied depending on culture associates. 
When cultured with NRS bacteria or rabbit intestinal flora, these trophozoites caused 
acute disease in animals but very little disease when cultured with Trypanosoma cruzi. 
Reassociation with rabbit flora returned their infectivity. Wittner and Rosenbaum 
(1970) showed that direct association of E. histolytica with viable bacteria was required 
for virulence. Heat killed or glutaraldehyde-fixed bacteria do not increase virulence. 
Soluble bacterial factors were not implicated. Bracha and Mirelman (1984) showed that 
E. histolytica exposed to live bacteria (that are known to adhere amoeba) for 30 min, 
increased in virulence in in vivo measurement, however it appears that association with 
bacteria is not an absolute requirement for invasion by E. histolytica. Association of 
specific bacteria with E. histolytica could change the architecture of the cell surface 
leading to altered properties of the cell (Bhattacharya et al 1992a). 
 
 
4.2  Adherence to establish direct contact between trophozoite and target cell 
 
Adherence of trophozoites to target cells is a necessary prerequisite for cytotoxicity. 
Evidence for this is provided by the following observations. Cinemicrography of 
amoeba interacting with CHO cells on a glass coverslip showed that the CHO cells in 
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direct contact with amoeba displayed membrane blebbing and release from cover slip, 
while those not in direct contact, remained viable. When CHO cells and trophozoites 
were mixed and incubated in the presence of high molecular weight dextran (10%), 
lysis did not occur as dextran prevented adherence of trophozoites to target cells 
(Ravdin and Guerrant 1981). In another experiment erythrocytes and trophozoites 
were mixed so as to allow adherence. Cells were centrifuged through a Ficoll gradient. 
Trophozoites that banded on top of the gradient had not adhered to erythrocytes. 
These were found to be much less virulent in a hamster liver model. 
Adherence to CHO cells at 37°C is inhibited by cytochalasins Β and D, implicating 
the need for intact amoebic microfilament function in the process (Ravdin and 
Guerrant 1981). Adherence is also inhibited by the Ca2+ channel blocker, Bepridil 
possibly by preventing intracellular Ca2+ flux which is thought to be necessary for 
microfilament function (Ravdin et al 1985b). 
Two surface molecules responsible for adherence have been identified—one inhibit- 
able by galactose or N-acetyl-D-galactosamine (GalNAc) (Bracha and Mirelman 1983; 
Petri et al 1987; Ravdin and Guerrant 1981; Ravdin et al 1985c) and the other 
inhibitable by N-acetyl-D-glucosamine (GlcNAc) polymers (Kobiler and Mirelman 
1981). Pretreatment of amoeba with galactose or GalNAc inhibits adherence whereas 
pretreatment with neuraminic acid, maltose, mannose and GlcNAc has no effect. The 
Gal/GalNAc inhibitable lectin of E. histolytica has been characterized in considerable 
detail (reviewed in McCoy 1994). The following data suggest that this molecule plays 
an essential role in amoebic adherence to target cells (i) binding of trophozoites to 
CHO cells was inhibited 90-95% by 50 mM galactose and GalNAc while other 
sugars had no effect (Chadee 1987, 1988; Ravdin and Guerrant 1981; Ravdin et al 
1985a; Salata et al 1985a; Salata and Ravdin 1986), (ii) a mutant of CHO cell defective 
in production of N- and O-linked galactose-terminal oligosaccharides was almost 
completely resistant to adherence, (iii) complex branched polysaccharides containing 
galactose groups at their termini were 1,000-fold more effective by weight than 
galactose, in inhibiting adherence to CHO cells (Petri et al 1987). The lectin has a 
molecular weight of 260 kDa and dissociates into heavy (170 kDa) and light (35-31 kDa) 
subunits in sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
(Petri et al 1989). Three genes (hgl 1-3) encoding the 170 kDa subunit have been 
identified and characterized (Mann et al 1991; Purdy et al 1993; Tannich et al 1991). 
Analysis of deduced amino acid sequences of the three genes indicate that this subunit 
of the lectin is a transmembrane protein. Northern blot analyses show that all the 
three genes are expressed in E. histolytica and the mRNAs were of the same size 
(4·0 kb) (Mann et al 1991; Purdy et al 1993; Tannich et al 1991). Two light subunit genes 
(lgl 1-2) have also been identified and characterized (McCoy et al 1993a, b; Tannich 
et al 1992). These genes have hydrophobic amino- and carboxy-terminal signal se- 
quences. The 31 kDa isoform of the light subunit has a putative glycosylphos- 
phatidylinositol (GPI) anchor cleavage/addition site while the 35 kDa isoform seems to 
lack it. Lectin heterodimers have been identified by two dimensional gel electrophor- 
esis. The purified lectin showed atleast two major heterodimers, one containing the 
170 kDa subunit.with 35 kDa isoform and another 170 and 31 kDa isoform. Minor 
heterodimers with 160 and 150 kDa heavy subunit isoforms were also present (McCoy 
et al 1993b). The native lectin probably exists as oligomers of 400 kDa and 660 kDa. 
Apart from its function in adherence the lectin appears to mediate amoebic resistance 
to complement lysis. 
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4.3  Lysis of target cells by release of toxins and introduction of membrane channels 
 
Prior to mucosal invasion by E. histolytica there is depletion of mucous and disruption 
of epithelial barrier. Cytolysis of the target cell is thought to require amoebic microfila- 
ment function, Ca2+ flux and phospholipase A, among others. Microfilament function 
seems to be necessary because lysis is inhibited at 25°C, a temperature at which actin 
gelation ceases (Pollard 1976); the optimal temperature being 37°C. Studies with the 
Ca2+-binding fluorescent dye FURA-2 showed 20-fold increase in intracellular Ca2+ 
in target cells within seconds of direct contact. Actual cell death occurred 5-15 min 
after the lethal hit. Possible roles of Ca2+ are in contact-dependent release of cytotoxic 
enzymes and toxins, cytoskeletal changes and activation of Ca2 +-dependent enzymes, 
for example, phospholipases. 
Bos (1979) proposed that E. histolytica has two ways of killing host cells—one is 
a rapid process occurring at close contact; other is slow, operating through soluble 
substances. Contact-dependent cytolethal effect of E. histolytica is not inhibited by 
serum but contact-independent effect is inhibited. Lushbaugh et al (1978a, b) showed 
that cell-free extracts from axenically grown trophozoites caused cytopathic effect on 
cell cultures, in the absence of serum. Lushbaugh et al (1979) and Bos (1979) indepen- 
dently purified a "cytotoxic" substance from trophozoite extracts which caused cell 
rounding and release from monolayer. The activity was associated with a protein 
(34-40 kDa) activated by thiols (Bos et al 1980). It is believed that these thiol-proteases 
may be one of the molecules involved in pathogenesis (McKerrow 1993). This is based 
on the fact that there seems to be a correlation between clinical severity with the level of 
thiol protease in clinical isolates (Reed et al 1989). HM- 1:IMSS (more virulent of the 
two strains) has greater thiol protease activity than HK-9 strain (Gadasi and Kobiler 
1983; Lushbaugh et al 1989). Patients with invasive disease produce antibodies against 
this enzyme; those with non-invasive disease do not (Reed et al 1989). The enzyme has 
broad substrate specificity. It can utilize casein, gelatin, insulin, type I collagen, 
fibronectin and laminin as substrates (Keene et al 1986; Luaces and Barrett 1988;
Scholze and Schulte 1988; Scholze and Werries 1986; Schulte et al 1987). It is
a cathepsin B-like enzyme. Similar enzymes are found in extracellular milieu of invasive 
tumour cells (Lushbaugh 1988). The protease may assist trophozoite to gain access to 
target cells by degrading the extracellular matrix. 
A candidate for the toxin responsible for cytolysis may be a pore-forming peptide. 
Various amoebic pore-forming proteins (30, 14 and 5 kDa proteins) have been de- 
scribed (Dodson and Petri 1994). A 30 kDa amoebic protein was purified and shown to 
lyse erythrocytes and insert into and create pores in lipid bilayers. A 14 kDa pore- 
forming protein was described as an ion-channel forming protein. Of these the 5 kDa 
protein (amoebapore) has been the best characterized (Leippe et al 1991, 1992). The 
primary structure of the 5 kDa amoebapore from pathogenic E. histolytica was deter- 
mined by sequencing the purified peptide and the corresponding cDNA. It is composed 
of 77 amino acids, including 6 cysteine residues. Like other membrane-penetrating 
polypeptides, it too has an all α helical conformation. 
The cellular immune response of the host may contribute to destruction of the local 
host tissue. In hamster liver model recruitment of neutrophils is the initial host response 
to E. histolytica infection (Tsutsumi et al 1984). Neutrophils are lysed when they come 
in contact with E. histolytica trophozoites releasing toxic products which lyse distant 
hepatocytes (Salata and Ravdin 1986). 
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Leukocytes have the potential to lyse E. histolytica trophozoites and vice versa. 
E. histolytica is cytolytic to human leukocytes on contact. Only virulent amoeba can 
lyse polymorphonuclear leukocytes (PMNs) and lysis is blocked by GalNAc. At a ratio 
of 1000 PMNs per amoeba, trophozoites of the highly virulent strain HM-1:IMSS 
were not killed but those of the less virulent strain 303 were killed (Guerrant et al 1981). 
At a ratio of 100 PMNs per amoeba, HM- 1:IMSS trophozoites killed a high percen- 
tage of PMNs while killing was less with 303 trophozoites. Ε. histolytica could kill 
macrophages and Τ lymphocytes in vitro. Conversely, macrophages activated with 
concanavalin A could kill amoeba. Τ lymphocytes from immune individuals, following 
incubation with amoebic antigen, were capable of killing E. histolytica trophozoites 
(Salata and Ravdin 1985b). 
 
 
4.4  Phagocytosis 
 
Trophozoites from stools of many invasive patients contain ingested erythrocytes 
and have much higher rate of erythrophagocytosis than healthy human carrier. 
Phagocytosis of mammalian tissue culture grown cells was observed by transmission 
electron microscopy. Cells with intact plasma membrane were phagocytosed, showing 
that prior cell lysis was not required for endocytosis (McCaul 1977). A phagocytosis- 
deficient mutant of E. histolytica has been isolated by Orozco et al (1983). This mutant 
apart from being poor in phagocytosis, was also found to be low in virulence, when 
tested in the hamster liver model. Thus there seems to be a correlation between 
phagocytosis and virulence. 
 
 
5.  "Pathogenic" vs "nonpathogenic" amoebae 
 
The vast majority of E. histolytica infections are asymptomatic. Are these caused by
nonpathogenic strains of the parasite, in contrast with invasive infection resulting 
from pathogenic strains; or are all E. histolytica strains pathogenic and host factors 
decide the course of infection. If strain differences exist, then the molecular basis of 
pathogenicity could be elucidated by looking for missing functions in non pathogenic 
strains. Isoenzyme comparisons (zymodemes) of E. histolytica grown from asympto- 
matic cyst passers and patients suffering from invasive disease showed that clearly 
different parasite strains were involved (Sargeaunt et al. 1978). Infact, the strains found 
in asymptomatic individuals (nonpathogenic) were so distant from pathogenic strains 
that they have now been accorded a separate species status, namely E. dispar (Diamond 
and Clark 1993); and the name E. histolytica has been retained for the pathogenic 
strains. 
Of the molecules implicated in pathogenesis, the amoebapore and cysteine proteinases 
from Ε. dispar have been analysed in some detail. Both proteins do exist in E. dispar, 
although differing considerably from the homologous proteins in E. histolytica. The 
specific activity of E. dispar amoebapore is less than half that of E. histolytica (Leippe 
et al 1993). The two peptides differ in four amino acid residues, of which the substitu- 
tion of glu in the E. histolytica peptide with pro in the E. dispar peptide is significant. 
This change lies in an amphipathic α helix in the NH2-terminal part of amoebapore. 
Since pro is known to disrupt α-helices, this substitution would shorten the am- 
phipathic helix by 2 residues which could lead to reduction in pore-forming activity. 
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The natural function of the E. dispar amoebapore may be to kill phagocytosed bacteria 
rather than host cells. 
When the 27 kDa cysteine proteinase of E. dispar was compared with the homologous 
enzyme in Ε. histolytica, the two proteins were found to be 83% homologous by 
deduced amino acid sequence (Tannich et al 1991). The residues thought to be 
important for proteolytic function (by comparison with X-ray crystallographic data on 
papain) are conserved in the two proteins. Thus, the enzyme from E. dispar may not 
differ functionally from that in E. histolytica. However, Northern blot analysis revealed 
that the E. dispar enzyme was expressed at 10-l00-fold lower level than the 
E. histolytica enzyme. The E. dispar enzyme may therefore be confined to the vacuo- 
lar/lysosomal cellular compartment while the over expressed Ε. histolytica enzyme 
may be secreted extracellulalry, which may be the crucial difference leading to 
pathogenicity. 
From the limited information available so far, it appears that the property of 
pathogenesis is determined more by quantitative levels of key molecules than by the 
total absence of these in nonpathogenic species. Further molecular analysis of absence 
in E. dispar and comparison with E. histolytica is required to arrive at meaningful 
conclusions. 
 
 
6.  Future perspectives 
 
A deeper understanding of pathogenesis in amoebiasis would require parallel insights 
into the cell biology and genetics of E. histolytica. This parasite is a fascinating 
biological system. It seems to lack typical eukaryotic organelles like mitochondria and 
Golgi bodies. Yet, genes for certain typically mitochondrial proteins, namely pyridine 
nucleotide transhydrogenase and the chaperonin cpn60, can be detected (Clark and 
Roger 1995). A novel lipophosphoglycan, which is present only in some protozoan 
parasites, has been discovered in E. histolytica. This molecule coats the trophozoite 
surface and is a variable surface antigen (Bhattacharya et al 1992b). Genetic analysis of 
E. histolytica has not been possible so far. However, DNA can now be introduced into 
this cell by electroporation (Nickel and Tannich 1994; Purdy et al 1994; Vines et al 
1995) paving the way for genetic analysis of specific functions. These developments 
should ultimately lead to breakthroughs in answering the central question of 
pathogenesis of infection by E. histolytica. 
 
 
Acknowledgement 
 
DS was a recipient of fellowship from the Council of Scientific and Industrial Research, 
New Delhi. 
 
 
References 
 
Bhattacharya A, Ghildyal R, Prasad J, Bhattacharya S and Diamond L S 1992a Modulation of a surface 
antigen οf Entamoeba histolytica in response to bacteria; Infect. Immun. 60 1711-1713 
Bhattacharya A, Prasad R and Sacks D 1992b Identification and partial characterization of a lipophospho- 
glycan-like molecule from a pathogenic strain of Entamoeba histolytica; Mol. Biochem. Parasitol. 56 
161-168 
430 Devinder Sehgal et al 
 
Bos Η J 1979 Entamoeba histolytica: cytopathogenicity of intact amoeba and cell-free extracts: isolation and 
characterization of an intracellular toxin; Exp. Parasitol. 47 369-377 
Bos Η J, Leijendekker W J and van den Eijk A A 1980 Entamoeba histolytica: cytopathogenicity, including 
serum effects on contact-dependent and toxin-induced lysis of hamster kidney cell monolayers; Exp. 
Parastiol. 50 342-348 
Bracha R, Kobiler D and Mirelman D 1982 Attachment and ingestion of bacteria by trophozoites of 
Entamoeba histolytica; Infect. Immun. 36 396-406 
Bracha R and Mirelman D 1983 Adherence and ingestion of Escherichia coli serotype 055 by trophozoites of 
Entamoeba histolytica; Infect. Immun. 40 882-887 
Bracha R and Mirelman D 1984 Virulence of Entamoeba histolytica trophozoites: effects of bacteria, 
microaerobic conditions and metronidazole; J. Exp. Med. 160 353-368 
Brandt Η and Perez-Tamoyo 1970 Pathology of human amoebiasis; Hum. Pathol. 1 351-385 
Chadee K, Johnson Μ L, Orozco E, Petri W A and Ravdin J I 1988 Binding and internalization of rat colonic 
mucins by the galactose/N-acetyl-D-galactosamine adherene lectin of Entamoeba histolytica; J. Infect. 
Dis. 158 398-406 
Chadee Κ, Petri W A, Innes D J and Ravdin J I 1987 Rat and human colonic mucins bind to and inhibit the 
adherence lectin of Entamoeba histolytica; J. Clin. Invest. 80 1245-1254 
Clark C G and Roger A 1995 Direct evidence for secondary loss of mitochondria in Entamoeba histolytica; 
Proc. Natl. Acad. Sci. USA 92 6518-6521 
Diamond L S and Clark C G 1993 A redescription of E. histolytica Schaudinn, 1903 (Emended Walker, 1911) 
separating it from E. dispar Brumpt, 1925; J. Euk. Microbiol. 40 340-344 
Dodson J Μ and Petri W A 1994 Pore formation and cytolysis by Entamoeba histolytica; Parasitol. Today 10 7-8 
Gadasi Η and Kobiler D 1983 Entamoeba histolytica: correlation between virulence and content of 
proteolytic enzymes; Exp. Parasitol. 55 105-110 
Guerrant R L, Brush J, Ravdin J I, Sullivan J A and Mandell G L 1981 Interaction between Entamoeba 
histolytica and human polymorphonuclear neutrophils; J. Infect. Dis. 143 83-93 
Joyce Μ Ρ and Ravdin J I 1988 Pathology of Human amoebiasis: in Amoebiasis: Human infection by 
Entamoeba histolytica (ed.) J I Ravdin (New York: John Wiley) pp 129-146 
Keene W E, Petitt Μ A, Allen S and McKerrow J Η 1986 The major neutral proteinase of Entamoeba 
histolytica; J. Exp. Med. 163 536-549 
Kobiler D and Mirelman D 1981 Adhesion of Entamoeba histolytica trophozoites to monolayers of human 
cells; J. Infect. Dis. 144 539-546 
Leippe Μ, Bahr Ε, Tannich Ε and Horstmann R D 1993 Comparison of pore-forming peptides from 
pathogenic and nonpathogenic Ε. histolytica; Mol. Biochem. Parasitol. 59 101-110 
Leippe M, Ebel S, Schoenberger Ο L, Horstmann R D and Muller-Eberhard Η J 1991 Pore-forming peptide 
of pathogenic Entamoeba histolytica; Proc. Natl. Acad. Sci. USA 88 7659-7663 
Leippe Μ, Tannich Ε, Nickel R, Vandergoot G, Pattus F, Horstmann R D and Muller-Eberhard Η J 1992 
Primary and secondary structure of the pore forming peptide of pathogenic Entamoeba histolytica; 
EMBO J. 11 3501-3506 
Luaces A L and Barrett A J 1988 Affinity purification and biochemical characterization of histolysin, the 
major cysteine proteinase of Entamoeba histolytica; Biochem. J. 250 903-909 
Lushbaugh W Β 1988 Proteinases of Entamoeba histolytica; in Amoebiasis: Human infection by Entamoeba 
histolytica (ed.) J I Ravdin (New York: John Wiley) pp 219-231 
Lushbaugh W Β, Kairalla A B, Cantey J R, Hotbauer A F and Pittman F Ε 1979 Isolation of a cytotoxin- 
enterotoxin from Entamoeba histolytica; J. Inf. Dis. 139 9-17 
Lushbaugh W B, Kairalla A B, Cantey J R, Hofbauer A F, Pittman J C and Pittman F Ε 1978a Cytotoxicity 
of cell-free extracts of Entamoeba histolytica; Arch. Invest. Med. 9 233-236 
Lushbaugh W Β, Kairalla Α Β, Hofbauer A F, Cantey J R and Pittman F Ε 1978b Cytotoxic activity of 
a cell-free extracts of Entamoeba histolytica; Trans. R. Soc. Trop. Med. Hyg. 72 105-106 
Mann Β J, Torian Β Ε, Vedvick Τ S and Petri W A 1991 Sequence of a cysteine-rich galactose-specific lectin of 
Entamoeba histolytica; Proc. Natl. Acad. Sci. USA 88 3248-3252 
McCaul Τ F 1977 Transmission electron microscopy observation of phagocytosis in trophozoite of 
Entamoeba histolytica in contact with tissue culture cells; Z. Parasitentd. 52 203-211 
McCoy J J, Mann Β J and Petri W A 1994 Aherence and cytotoxicity of Entamoeba histolytica or How lectins 
let parasites stick around; Infect. Immun. 62 3045-3050 
McCoy J J, Mann Β J, Vedvick Τ S and Petri W A 1993a Sequence analysis of genes encoding the light 
subunit of Entamoeba histolytica galactose-specific adhesin; Mol. Biochem. Parasitol. 61 325-328 
Pathogenesis of amoebiasis 431 
 
McCoy J J, Mann Β J, Vedvick Τ S and Petri W A 1993b Structural analysis of light subunit οf Entamoeba 
histolytica galactose-specific adherence lectin; J. Biol. Chem. 268 24223-24231 
McKerrow J H, Sun Ε, Rosenthal Ρ J and Bouvier J 1993 The proteases and pathogenicity of parasitic 
protozoan; Annu. Rev. Microbiol. 47 821-853 
Meerovitch Ε and Chadee Κ 1988 In vivo models of pathogenicity in amoebiasis; in Amoebiasis: Human 
infection by Entamoeba histolytica (ed.) J I Ravdin (New York: John Wiley) pp 177-190 
Nickel R and Tannich Ε 1994 Transfection and transient expression of chloramphenicol acetyltransferase 
gene in the protozoan parasite Entamoeba histolytica; Proc. Natl. Acad. Sci. USA 91 7095-7098 
Orozco Ε, Guarneros G, Martinez-Palomo A and Sanchez Τ 1983 Entamoeba histolytica: phagocytosis as 
a virulence factors; J. Exp. Med. 158 1511-1521 
Petri W A, Chapman Μ D, Snodgrass Τ L, Mann Β J, Broman J and Ravdin J I 1989 Subunit structure of the 
galactose and N-acetyl-D-galactosamine-inhibitable adherence lectin of Entamoeba histolytica; J. Biol. 
Chem. 264 3007-3012 
Petri W A and Ravdin J I 1988 In vitro models of amoebic pathogenesis; in Amoebiasis: Human infection by 
Entamoeba histolytica (ed.) J I Ravdin (John Wiley) pp 191-204 
Petri W A, Smith R D, Schlesinger Ρ Η, Murphy C F and Ravdin J I 1987 Isolation of a galactose-binding 
lectin that mediates the in vitro adherence of Entamoeba histolytica; J. Clin. Invest. 80 1238-1244 
Pittman F Ε, El-Hashimi W Κ and Pittman J C 1973 Studies of human amoebiasis. II Light and 
electron-microscopic observations of colonic mucosa and exudate in acute amoebic colitis; Gastroentero- 
logy 65 588-603 
Pittman F Ε and Hennigar G R 1974 Sigmoidoscopic and colonic mucosal biopsy finding in amoebic colitis; 
Arch. Pathol. 97 155-158 
Pollard Τ D 1976 The role of actin in the temperature-dependent gelation and contraction of extracts of 
Acanthamoeba; J. Cell. Biol. 68 579-601 
Prathap Κ and Gilman R 1970 The histology of acute intestinal amoebiasis: a rectal biopsy study; Am. J. 
Pathol. 60 229-246 
Purdy J Ε, Mann Β J, Pho L and Petri W A 1994 Transient transfection of the enteric parasite Entamoeba 
histolytica and expression of firefly luciferase; Proc. Natl. Acad. Sci. USA 91 7099-7103 
Purdy J E, Mann Β J, Shigart Ε C and Petri W A 1993 Analysis of the gene family encoding the Entamoeba 
histolytica galactose-specific adhesin 170-kDa subunit; Mol. Biochem. Parasitol. 62 53-60 
Ravdin J I, John J E, Jonston L I, Innes D J and Guerrant R L 1985a Adherence of Entamoeba histolytica 
trophozoites to rat and human colonic mucosa; Infect. Immun. 48 292-297 
Ravdin J I, Murphy C F, Guerrant R L and Long-Krug S A 1985b Effect of calcium and phospholipase 
A antagonists in the cytopathogenicity of Entamoeba histolytica; J. Infect. Dis. 152 542-549 
Ravdin J I and Guerrant R L 1981 Role of adherence in cytopathogenic mechanisms of Entamoeba histolytica: 
study with mammalian tissue culture cells and human erythrocytes; J. Clin. Invest. 68 1305-1313 
Ravdin J I, Murphy C F, Salata R A, Guerrant R L and Hewlett Ε L 1985c N-Acetyl-D-galactosamine- 
inhibitable adherence lectine of Entamoeba histolytica I. Partial purification and relation to amoebic 
virulence in vitro; J. Infect. Dis. 151 804-815 
Reed S, Keene W Ε and McKerrow J Η 1989 Thiol protease expression correlates with pathogenicity of 
Entamoeba histolytica; J. Clin. Microbiol. 27 2772-2777 
Salata R A, Pearson R Ρ, Murphy C F and Ravdin J I 1985 Interaction of human leukocytes with Entamoeba 
histolytica: killing of virulent amoebae by macrophage; J. Clin. Invest. 76 491-499 
Salata R A and Ravdin J I 1985 N-acetyl-D-galactosamine-inhibitable lectin of Entamoeba histolytica II. 
Mitogenic activity for human lymphocytes; J. Infect. Dis. 151 816-822 
Salata R A and Ravdin J I 1986 The interaction of human neutrophils and Entamoeba histolytica 
trophozoites increases cytopathogenicity for liver cell monolayers; J. Infect. Dis. 154 19-26 
Sargeaunt Ρ G, Williams J Ε and Green J D 1978 The differentiation of invasive and noninvasive 
Ε. histolytica by isoenzyme electrophoresis. Trans. R. Soc. Trop. Med. Hyg. 72 519-521 
Schulte W, Scholze Η and Werries Ε 1987 Specificity of a cysteine proteinase of Entamoeba histolytica 
towards the α1-CB2 peptide of bovine collagen type I; Mol. Biochem. Parasitol. 25 39-43 
Scholze Η and Schulte W 1988 On the specificity of a cysteine proteinase from Entamoeba histolytica; Biomed. 
Biochem. Acta 47 115-123 
Scholze Η and Werries Ε 1986 Cysteine proteinase of Entamoeba histolytica I. Partial purification and action 
on different enzymes; Mol. Biochem. Parasitol. 18 103-112 
Tannich Ε, Ebert F and Horstmann R D 1991 Primary structure of the 170-kilodalton surface lectin of 
pathogenic Entamoeba histolytica; Proc. Natl. Acad. Sci. USA 88 1849-1853 
432 Devinder Sehgal et al 
 
Tannich E, Ebert F and Horstmann R D 1992 Molecular cloning of cDNA and genomic sequences coding for 
the 35-kilodalton subunit of the galactose-inhibitable lectin of pathogenic Entamoeba histolytica; Mol. 
Biochem. Parasitol. 55 225-228 
Tannich Ε, Scholze Η, Nickel R and Horstmann R D 1991 Homologous cysteine proteinase of pathogenic 
and nonpathogenic Ε. histolytica; J. Biol. Chem. 266 4798-4803 
Tsutsumi V, Mena-Lopez R, Anaya-Velazquez F and Martinez- Palamo A 1984 Cellular basis of experimen- 
tal amebic liver abscess formation; Am. J. Pathol 117 81-91 
Vines R R, Purdy J Ε, Ragland Β D, Samuelson J, Mann Β J and Petri W A 1995 Stable episomal transfection 
of Entamoeba histolytica; Mol. Biochem. Parasitol.71265-267 
Walsh J A 1986 Problems in recognition and diagnosis of amoebiasis: estimation of the global magnitude of 
morbidity and mortality; Rev. Infect. Dis. 8 228-238 
Wittner Μ and Rosenbaum R Μ 1970 Role of bacteria in modifying virulence of Entamoeba histolytica; Am. 
 J, Trop. Med. Hyg. 19 755-761 
